Edesa Biotech is trading 10.96% up at $3.95 before the September 30, 2026 session, versus the September 29 close of $3.56; no specific catalyst has been identified. - The supplied context records a 6.46% after-hours gain to $3.79 on September 29. - The company’s official news page lists its August 19 public-offering announcements as its latest releases, with no September 29 or 30 announcement shown. Available evidence does not establish a company-specific or broader-market cause.